5 results
8-K
EX-99.1
VIR
Vir Biotechnology Inc
21 May 21
CORRECTION — EMA Issues Positive Scientific Opinion on GSK and Vir Biotechnology’s
3:38pm
% were Black or African American. According to the U.S. Centers for Disease Control and Prevention, these populations are approximately three times more
8-K
EX-99.1
VIR
Vir Biotechnology Inc
27 May 21
GSK and Vir Biotechnology Announce Sotrovimab (VIR-7831) Receives
4:55pm
arm and 438 in the placebo arm) through day 15. Among those studied, 63% were Hispanic or Latino and 7% were Black or African American. According
- Prev
- 1
- Next